Wms Partners Raised Mastercard (MA) Holding by $350,056 as Share Value Rose; Chemocentryx (CCXI) Shareholder Vanguard Group Has Increased Stake

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Vanguard Group Inc increased its stake in Chemocentryx Inc (CCXI) by 2.33% based on its latest 2018Q4 regulatory filing with the SEC. Vanguard Group Inc bought 30,990 shares as the company’s stock rose 6.99% with the market. The institutional investor held 1.36M shares of the health care company at the end of 2018Q4, valued at $14.84 million, up from 1.33M at the end of the previous reported quarter. Vanguard Group Inc who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $547.25M market cap company. The stock increased 1.86% or $0.19 during the last trading session, reaching $10.41. About 101,874 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since March 15, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 ChemoCentryx 4Q EPS 80c; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19

Wms Partners Llc increased its stake in Mastercard Incorporated (MA) by 16.34% based on its latest 2018Q4 regulatory filing with the SEC. Wms Partners Llc bought 1,862 shares as the company’s stock rose 11.87% with the market. The hedge fund held 13,258 shares of the business services company at the end of 2018Q4, valued at $2.50 million, up from 11,396 at the end of the previous reported quarter. Wms Partners Llc who had been investing in Mastercard Incorporated for a number of months, seems to be bullish on the $237.69 billion market cap company. The stock increased 0.95% or $2.18 during the last trading session, reaching $231.69. About 1.76 million shares traded. Mastercard Incorporated (NYSE:MA) has risen 30.43% since March 15, 2018 and is uptrending. It has outperformed by 26.06% the S&P500.

Since November 2, 2018, it had 1 buy, and 2 selling transactions for $4.52 million activity. McLaughlin Edward Grunde sold $4.04M worth of stock. Another trade for 5,000 shares valued at $959,993 was made by Haythornthwaite Richard on Monday, December 17.

Investors sentiment increased to 0.99 in 2018 Q4. Its up 0.02, from 0.97 in 2018Q3. It improved, as 75 investors sold MA shares while 494 reduced holdings. 113 funds opened positions while 453 raised stakes. 806.08 million shares or 9.71% more from 734.72 million shares in 2018Q3 were reported. Psagot Invest House Ltd has invested 0.48% in Mastercard Incorporated (NYSE:MA). Colony Group Lc has 1.13% invested in Mastercard Incorporated (NYSE:MA) for 123,699 shares. Ami Asset holds 201,374 shares or 3.14% of its portfolio. Moreover, Boyd Watterson Asset Management Ltd Oh has 0.72% invested in Mastercard Incorporated (NYSE:MA). Spectrum Asset Management (Nb Ca) has invested 0.92% in Mastercard Incorporated (NYSE:MA). The Arizona-based Arizona State Retirement System has invested 0.51% in Mastercard Incorporated (NYSE:MA). Advisor Prtn Ltd Com reported 23,334 shares. Transamerica Financial accumulated 1,352 shares. Girard Prtnrs holds 12,892 shares or 0.51% of its portfolio. Capstone Inv Advsr Ltd owns 1,629 shares. Northern Limited Liability owns 5,375 shares or 0.27% of their US portfolio. Vulcan Value Ltd Limited Liability Company holds 6.39% in Mastercard Incorporated (NYSE:MA) or 3.67 million shares. Alkeon Management Lc has 847,803 shares for 1.04% of their portfolio. Wallace owns 1,100 shares or 0.03% of their US portfolio. B And T Cap Mngmt Dba Alpha Cap Mngmt has invested 0.69% of its portfolio in Mastercard Incorporated (NYSE:MA).

More notable recent Mastercard Incorporated (NYSE:MA) news were published by: Seekingalpha.com which released: “Mastercard gives China another try – Seeking Alpha” on February 22, 2019, also Seekingalpha.com with their article: “Bernstein bullish on Visa, Mastercard cross-border payments prospects – Seeking Alpha” published on March 05, 2019, Seekingalpha.com published: “Should Mastercard Be Bought Here? – Seeking Alpha” on February 20, 2019. More interesting news about Mastercard Incorporated (NYSE:MA) were released by: Fool.com and their article: “Better Buy: Mastercard vs. Discover – The Motley Fool” published on February 17, 2019 as well as Seekingalpha.com‘s news article titled: “U.S. weighs banning transaction-processing in Venezuela: Bloomberg – Seeking Alpha” with publication date: March 14, 2019.

Wms Partners Llc, which manages about $2.55B and $357.54M US Long portfolio, decreased its stake in Capital One Finl Corp (NYSE:COF) by 152,110 shares to 11,087 shares, valued at $838,000 in 2018Q4, according to the filing. It also reduced its holding in Cisco Sys Inc (NASDAQ:CSCO) by 438,400 shares in the quarter, leaving it with 52,059 shares, and cut its stake in Oracle Corp (NYSE:ORCL).

Vanguard Group Inc, which manages about $2225.64 billion US Long portfolio, decreased its stake in Five Prime Therapeutics Inc (NASDAQ:FPRX) by 903,768 shares to 1.35M shares, valued at $12.54 million in 2018Q4, according to the filing. It also reduced its holding in Yum Brands Inc (NYSE:YUM) by 160,158 shares in the quarter, leaving it with 23.09M shares, and cut its stake in Third Pt Reins Ltd (NYSE:TPRE).

Since October 16, 2018, it had 0 buys, and 8 sales for $87.64 million activity. The insider Schall Thomas J. sold 7,211 shares worth $86,554. GLAXOSMITHKLINE PLC sold $85.85M worth of ChemoCentryx, Inc. (NASDAQ:CCXI) on Tuesday, October 16. 37,893 shares were sold by KANAYA SUSAN M, worth $457,747.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx Announces Proposed Public Offering of Common Stock – GlobeNewswire” on September 26, 2018, also Seekingalpha.com with their article: “ChemoCentryx launches $75M stock offering – Seeking Alpha” published on September 26, 2018, Nasdaq.com published: “ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates – Nasdaq” on March 11, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx terminates previously announced common stock offering – Seeking Alpha” published on September 28, 2018 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx: Discounted, Underfollowed, And Misunderstood Biotech – Seeking Alpha” with publication date: May 07, 2018.

Mastercard Incorporated (NYSE:MA) Institutional Positions Chart


Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *